Funds to accelerate clinic expansion, AI-driven treatment protocols, and patient-first healthcare innovations. Now operating ...

The lineup includes Government Cheese, Jane Season 3, Carême, and Your Friends & Neighbors. The post Apple TV+ April 2025 ...

Century Therapeutics, Inc. (NASDAQ: IPSC) outlined a strategic pipeline re-prioritization and shared its financial results ...

Older patients and those with genetic risk factors were at particularly high risk of relapse and had poorer overall survival.

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its price objective decreased by HC Wainwright from $9.00 to $8.00 in a ...

Zerodha CEO Nithin Kamath emphasizes the principle of treating others well while celebrating his EY Entrepreneur Of The Year ...

PHILADELPHIA, March 19, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell ...

Leadership Scotts Bluff will present Hoops for Heroes, its' annual fundraising event Friday. The event will be held from 5:30 ...

In a report released on March 14, Matthew Biegler from Oppenheimer reiterated a Buy rating on Allogene Therapeutics (ALLO – Research Report), ...

In a report released yesterday, Benjamin Burnett from Stifel Nicolaus maintained a Hold rating on Allogene Therapeutics (ALLO – Research ...

Canaccord Genuity Group reaffirmed their buy rating on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a ...